Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alpha-1 Antitrypsin in STEMI
NCT01936896Phase 2Completed
- Sponsor
- Virginia Commonwealth University
- Start
- Dec 2013
- Primary completion
- Jun 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of alpha-1-proteinase inhibitor in ST-segment elevation myocardial infarction (STEMI), sponsored by Virginia Commonwealth University. Started Dec 2013; status: completed.
02
Drugs
alpha-1-proteinase inhibitor
03
Conditions
ST-segment elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT01936896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01936896.